{
    "NCT06228807": {
        "model_response": [
            "Excellent! Including these secondary outcome measures will provide a comprehensive understanding of the study population and their clinical characteristics, medical history, laboratory biomarkers, echocardiographic measurements, angiographic findings, and clinical outcomes. This information will be crucial for identifying predictors of adverse outcomes in HFpEF patients.",
            "You're welcome! I'm glad I could assist you. If you have any more questions or need further assistance in the future, feel free to reach out. Good luck with your clinical trial!"
        ],
        "groundtruth": [
            "Excellent choices! By incorporating these secondary outcome measures, you'll gain a comprehensive understanding of the study population and identify potential predictors of adverse outcomes. Monitoring these parameters over time will provide valuable longitudinal data to track disease progression, response to treatment, and overall prognosis in HFpEF patients. This information will be crucial for risk stratification and tailored management strategies. Is there anything else I can help you with regarding the outcome measures?",
            "You're welcome! I'm glad I could help. If you have any more questions or need further assistance in the future, feel free to reach out. Good luck with your clinical trial!"
        ]
    }
}